Almeda Ventures Limited Partnership (TLV:AMDA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 180.30
+2.80 (1.58%)
At close: Aug 6, 2025
TLV:AMDA Revenue
In the year 2024, Almeda Ventures Limited Partnership had annual revenue of $-3.02M USD with 932.88% growth. Almeda Ventures Limited Partnership had revenue of $-2.25M in the half year ending December 31, 2024, a decrease of -374.79%.
Revenue
$-3.02M
Revenue Growth
+932.88%
P/S Ratio
-2.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
30.56M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | -3.02M | -2.72M | 932.88% |
| Dec 31, 2023 | -292.00K | -1.20M | -132.19% |
| Dec 31, 2022 | 907.00K | -690.00K | -43.21% |
| Dec 31, 2021 | 1.60M | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| SofWave Medical | 234.12M |
| BrainsWay | 161.81M |
| Novolog (Pharm-Up 1966) | 2.07B |
| Ilex Medical | 922.08M |